BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Compounds/Trametinib
✓ FULLY PROFILED

Trametinib

296+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

Trametinib 2D molecular structure
PubMed Studies
296+
Targets
6
Pathways
10
Molecular Targets
MAP2K1MAP2K2DUALABCB1MAPK1MAPK3

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways
mTORAPOPTOSISINFLAMMATIONSTEM_CELLSINSULIN_SIGNALINGGLUCOSE_METABOLISMPROTEOSTASISAUTOPHAGYIMMUNE_FUNCTIONAMPK

Biological pathways associated with Trametinib based on target analysis.

Biological Mechanisms
mTORmTORNF-κBNF-κBIRSInsulin SignalingATGAutophagyNLRP3NLRP3 InflammasomeAMPKAMPK

Biological mechanisms activated or modulated by Trametinib based on pathway and target analysis.

Health Goals
Longevity →Neuroprotection →Inflammation →Immune Support →Energy →

Health goals where Trametinib ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions
Alzheimer's →Chronic Inflammation →Arthritis →Type 2 Diabetes →Metabolic Syndrome →

Health conditions associated with the biological pathways influenced by Trametinib.

External References
PubChem CID 11707110 →296 PubMed studies →
Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Find similar compounds to Trametinib →
Data Source
Corpusv20260307-01
PubMed studies296
PubChem CID11707110
SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Trametinib is generated from 296 PubMed-indexed studies. Key molecular targets include MAP2K1, MAP2K2, DUAL. Associated biological pathways: mTOR, APOPTOSIS, INFLAMMATION. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.